U.S. equities rose at midday ahead of the latest announcement from the Federal Reserve, as President Donald Trump again ...

Stifel Financial downgraded Zoetis stock on Wednesday, causing the animal health company’s shares to fall 4% on the news. The ...

Zoetis Inc. closed 19.30% below its 52-week high of $200.33, which the company achieved on September 19th.

Infosys has announced a strategic partnership with Zoetis to enhance the latter's IT operations using AI and automation. This ...

Zoetis was created in 2013 after splitting off from Pfizer’s animal health division. While it may not seem like a household ...

Infosys announced a strategic collaboration with Zoetis, the world's leading animal health company. This long-term engagement aims to enhance Zoetis' IT operations and digital capabilities by ...

Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

Fintel reports that on June 18, 2025, Stifel downgraded their outlook for Zoetis (NYSE:ZTS) from Buy to Hold. Analyst Price ...

Zoetis Inc. closed 17.97% short of its 52-week high of $200.33, which the company reached on September 19th.

Buying $1000 In ZTS: If an investor had bought $1000 of ZTS stock 10 years ago, it would be worth $3,123.56 today based on a price of $156.87 for ZTS at the time of writing.